Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Dual Inhibition of Histone and DNA Methylation in AML Enhances the Effectiveness of TCR-Based Cellular Therapy through Upregulation of Surface MHC Class I/p53 Antigen Complex

Ulrike Regina Schmits, Edite Antunes Ferreira, Borhane Guezguez, David Gomez-Zepeda, Stefan Tenzer, Kevin Jan Legscha, Matthias Theobald, Hakim Echchannaoui

Blood (2024) 144 (Supplement 1): 3444.

https://doi.org/10.1182/blood-2024-201347

Published: 2024

Journal Articles

Transcutaneous Immunization with a Solid Nanoscopic Imiquimod Suspension Enhances Tumor Rejection

Pamela Stein, PhD, Karsten Gogoll, PhD, Tanja Peters, PhD, Mark Denny, Stefan Tenzer, PhD, Stefan Stevanovic, PhD, Hansjoerg Schild, PhD Prof., Matthias Theobald, MD PhD, Peter Langguth, Markus Radsak, MD

Blood (2015) 126 (23): 2224.

https://doi.org/10.1182/blood.V126.23.2224.2224

Published: 2015

Journal Articles

The Imatinib and Nilotinib Induced Modulation of the Proteasomal Activity and Antigen Processing in Chronic Myeloid Leukemia Cells

Stefanie AE Held, Annkristin Heine, MD, Stefan Tenzer, PhD, Anita Bringmann, PhD, Hansjoerg Schild, MD, Prof., Christoph Driessen, MD, Peter Brossart, MD

Blood (2011) 118 (21): 2748.

https://doi.org/10.1182/blood.V118.21.2748.2748

Published: 2011

Journal Articles

Imatinib Mesylate and Nilotinib Affect the MHC-Class I Presentation by Modulating the Proteasomal Processing of Antigenic Peptides.

Stefanie Held, Stefan Tenzer, Thomas Rückrich, Karin von Schwarzenberg, Anita Bringmann, Annkristin Heine, Hansjörg Schild, Christoph Driessen, MD, Peter Brossart, MD

Blood (2009) 114 (22): 2169.

https://doi.org/10.1182/blood.V114.22.2169.2169

Published: 2009

Journal Articles

A neoepitope generated by an FLT3 internal tandem duplication ( FLT3-ITD ) is recognized by leukemia-reactive autologous CD8 + T cells

Claudine Graf, Florian Heidel, Stefan Tenzer, Markus P. Radsak, Fian K. Solem, Cedrik M. Britten, Christoph Huber, Thomas Fischer, Thomas Wölfel

Blood (2006) 109 (7): 2985–2988.

https://doi.org/10.1182/blood-2006-07-032839

Published: 2006

Includes: Supplemental data

NARROW

Dual Inhibition of Histone and DNA Methylation in AML Enhances the Effectiveness of TCR-Based Cellular Therapy through Upregulation of Surface MHC Class I/p53 Antigen Complex

Transcutaneous Immunization with a Solid Nanoscopic Imiquimod Suspension Enhances Tumor Rejection

The Imatinib and Nilotinib Induced Modulation of the Proteasomal Activity and Antigen Processing in Chronic Myeloid Leukemia Cells

Imatinib Mesylate and Nilotinib Affect the MHC-Class I Presentation by Modulating the Proteasomal Processing of Antigenic Peptides.

A neoepitope generated by an FLT3 internal tandem duplication ( FLT3-ITD ) is recognized by leukemia-reactive autologous CD8 + T cells

Email alerts

ASH Publications

American Society of Hematology

Dual Inhibition of Histone and DNA Methylation in AML Enhances the Effectiveness of TCR-Based Cellular Therapy through Upregulation of Surface MHC Class I/p53 Antigen Complex

Transcutaneous Immunization with a Solid Nanoscopic Imiquimod Suspension Enhances Tumor Rejection

The Imatinib and Nilotinib Induced Modulation of the Proteasomal Activity and Antigen Processing in Chronic Myeloid Leukemia Cells

Imatinib Mesylate and Nilotinib Affect the MHC-Class I Presentation by Modulating the Proteasomal Processing of Antigenic Peptides.

A neoepitope generated by an FLT3 internal tandem duplication ( FLT3-ITD ) is recognized by leukemia-reactive autologous CD8 + T cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only